Stay updated on Intranasal Ketamine in Autism Social Impairment Clinical Trial
Sign up to get notified when there's something new on the Intranasal Ketamine in Autism Social Impairment Clinical Trial page.

Latest updates to the Intranasal Ketamine in Autism Social Impairment Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedThe page has undergone significant content changes, particularly the removal of detailed information about a study on intranasal ketamine for Autism Spectrum Disorder, including its purpose, methodology, and inclusion/exclusion criteria. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference28%
- Check43 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check87 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check101 days agoChange DetectedThe webpage now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference2%
- Check108 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
Stay in the know with updates to Intranasal Ketamine in Autism Social Impairment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intranasal Ketamine in Autism Social Impairment Clinical Trial page.